Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus

mBio(2024)10.1128/mbio.00609-24Source: DataRank Database

Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against Mycobacterium abscessus is a research paper published in mBio (2024). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (20)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Eunjeong Shin ORCID,Sebastian G. Kurz,Mark S. Plummer ORCID,Mary Nantongo ORCID,Christopher R. Bethel

Live enrichment

PubMed:38742824

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: R01AI100560, R01AI063517, R01AI072219

U.S. Department of Veterans Affairs

Grant: 1I01BX001974

National Institutes of Health

Grant: 5R01AI100560-04

A Mechanism-Based Approach to Metallo-beta-Lactamase Inhibition

National Institutes of Health

Grant: 5R01AI072219-12

Understanding B-Lactam Resistance in Acinetobacter baumannii

National Institutes of Health

Grant: 5R01AI063517-13

Challenges in beta-Lactamase Mediated Resistance

National Institutes of Health

Grant: 5I01BX001974-11

The Continuing Challenge of Carbapenemases in K. pneumoniae: KPC-2 & NDM-1

goldLicense: cc-by

publisherhttps://doi.org/10.1128/mbio.00609-24

publisherhttps://journals.asm.org/doi/pdf/10.1128/mbio.00609-24

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11237399/pdf/mbio.00609-24.pdf

https://doi.org/10.1101/2023.12.15.571879

https://pubmed.ncbi.nlm.nih.gov/38742824

Fields of Study

0301 basic medicine03 medical and health sciences

Keywords

570CefuroximeMycobacterium abscessus610Mycobacterium Infections, NontuberculousDrug SynergismMicrobial Sensitivity TestssulopenemMicrobiologyQR1-502Anti-Bacterial AgentsMolecular Docking Simulationoral carbapenemProhibitinsHumansdual β-lactamsbeta-Lactamase InhibitorsResearch Article

Sustainable Development Goals

SDG 3: 3. Good health